Doença congênita autossômica dominante que afeta os músculos esqueléticos. Microscopicamente, é caracterizada por áreas desorganizadas, chamadas núcleos, vistas geralmente no centro das fibras musculares. Clinicamente apresenta-se como fraqueza muscular leve a grave. Pode estar associada a anormalidades esqueléticas, incluindo escoliose, deformidades articulares e luxação do quadril.
Introdução
O que você precisa saber de cara
Doença congênita autossômica dominante que afeta os músculos esqueléticos. Microscopicamente, é caracterizada por áreas desorganizadas, chamadas núcleos, vistas geralmente no centro das fibras musculares. Clinicamente apresenta-se como fraqueza muscular leve a grave. Pode estar associada a anormalidades esqueléticas, incluindo escoliose, deformidades articulares e luxação do quadril.
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 16 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 43 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.
Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytosol and thereby plays a key role in triggering muscle contraction following depolarization of T-tubules (PubMed:11741831, PubMed:16163667, PubMed:18268335, PubMed:18650434, PubMed:26115329). Repeated very high-level exercise increases the open probability of the channel and leads to Ca(2+) leaking into the cytoplasm (PubMed:18268335). Can also mediate the release of Ca(2+)
Sarcoplasmic reticulum membrane
Malignant hyperthermia 1
Autosomal dominant pharmacogenetic disorder of skeletal muscle and is one of the main causes of death due to anesthesia. In susceptible people, an MH episode can be triggered by all commonly used inhalational anesthetics such as halothane and by depolarizing muscle relaxants such as succinylcholine. The clinical features of the myopathy are hyperthermia, accelerated muscle metabolism, contractures, metabolic acidosis, tachycardia and death, if not treated with the postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can be determined with the 'in vitro' contracture test (IVCT): observing the magnitude of contractures induced in strips of muscle tissue by caffeine alone and halothane alone. Patients with normal response are MH normal (MHN), those with abnormal response to caffeine alone or halothane alone are MH equivocal (MHE(C) and MHE(H) respectively).
Variantes genéticas (ClinVar)
6,385 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 3 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
2 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Doença do núcleo central
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
5 ensaios clínicos encontrados, 3 ativos.
Publicações mais relevantes
Molecular Insights into Central Core Disease: Proteomic Signatures and Potential Therapeutic Biomarkers in RYR1 I4895T Mice.
Central Core Disease (CCD) is a congenital myopathy predominantly caused by mutations in the gene encoding ryanodine receptor type-1 (RYR1), the intracellular Ca2+ release channel embedded in the skeletal muscle sarcoplasmic reticulum membrane. The I4898T mutation represents one of the most common RYR1 mutations associated with CCD. Unfortunately, there are no approved therapies for CCD or for other myopathies caused by mutations in this gene. This study aims to perform a top-down differential proteomic analysis on soleus muscle samples from wild-type mice (WT) and heterozygous knock-in mice carrying the I4895T (IT) mutation in RyR1, to investigate the pathogenic mechanisms and molecular pathways involved in this myopathy and to shed light on new potential biomarkers useful for future therapies. Proteomic analysis revealed 50 dysregulated protein species, and multivariate analysis showed that IT mice exhibit a distinct proteomic signature compared to WT mice, characterized by alterations in proteins associated with contractile and structural dysfunction, metabolism, and stress response. In particular, a significant increase in myosin fragments was observed in IT mice, likely due to muscle breakdown. In contrast, myotilin was downregulated, suggesting a weakening of the muscle cytoskeletal structure. There was a notable downregulation of proteins involved in glycolysis and the TCA cycle; conversely, there was an increase in proteins related to anaerobic glycolysis, suggesting a shift from aerobic to anaerobic glycolysis. Furthermore, proteins involved in fatty acid beta-oxidation and oxidative phosphorylation were also found to be upregulated in IT mice, indicating an attempt by the muscle to maximize energy production. Finally, we found a significant decrease in PGC1α, which could serve as potential therapy target and biomarker in CCD.
Ca2+, ROS, IL-6, and p38 MAPK signaling loops underlying alterations in myotube formation induced by a severe MH/CCD mutation in RyR1.
Mutations in the gene encoding the skeletal muscle ryanodine receptor (RyR1) can result in muscle diseases, termed RyR1-related myopathies (RyR1-RM). Examples include malignant hyperthermia (MH), central core disease (CCD), and centronuclear myopathy (CNM). The muscles involved often have more (and mispositioned) nuclei than normal. A subset of the corresponding mutant proteins shows an overactive or leaky sarcoplasmic reticulum (SR) channel behavior that depletes the SR Ca2+ content and increases the level of cytosolic Ca2+. In addition, two remarkable effects of these RyR1 variants have been reported in cultured myogenic cells: enhanced expression of interleukin-6 (IL-6) and stimulation of myoblast fusion (myonuclei accretion). Here, we have investigated whether the latter effect is due to a possible IL-6-dependent autocrine loop. Toward this goal, we analyzed the impact of the overactive Y523S mutant compared with the wild-type RyR1 after expression in C2C12 cells. The results show that this mutation indeed drastically promotes myoblast fusion up to ∼300%. Moreover, this action depends on the sequential activation of SR Ca2+ release, store-operated Ca2+ channels, reactive oxygen species (ROS, cytosolic and mitochondrial), calpain, and calcineurin. In addition, a neutralizing antibody directed against IL-6 and a p38 inhibitor completely suppressed the stimulation of myoblast fusion. Furthermore, in RyR1-expressing cells, myotube formation was promoted by either exogenous IL-6 or conditioned medium obtained from the Y523S-expressing cells. These findings suggest an autocrine mechanism involving the interplay between Ca2+, ROS, IL-6, and p38 signaling pathways in controlling myonuclei density, which could be essential to explain the pathogenesis of RyR1-RM.NEW & NOTEWORTHY Overactive RyR1 mutant proteins are associated with muscle disease; interestingly, they increase the number of myonuclei when expressed in C2C12 cells. We discovered that this alteration depends on a Ca2+/ROS loop, which recruits calpain and calcineurin to stimulate the production of IL-6 and the subsequent autocrine activation of p38. Thus, disease-causing RyR1 mutations require an IL-6 autocrine system to alter myonuclear density. This novel mechanism could be critical to understanding the pathogenesis of congenital myopathies.
Two journeys, one diagnosis: exploring the clinical outcomes of twins with congenital myopathy.
Mutations in the RYR1 gene, responsible for encoding the skeletal muscle calcium release channel, are linked to conditions such as malignant hyperthermia and central core disease. These mutations can severely affect calcium handling and excitation-contraction coupling, leading to different clinical manifestations including muscle fiber abnormalities. We present two siblings diagnosed with congenital myopathy due to a homozygous variant c.14,928 C > G (p.Phe4976Leu) in the RYR1 gene, inherited in an autosomal recessive pattern. Both twins, born prematurely via cesarean section, exhibited hypotonia and arthrogryposis. Clinical exome sequencing confirmed the RYR1 mutation, and an antioxidant supplement, idebenone, was introduced. Despite sharing the same variant, the twins presented discordant clinical phenotypes with varying degrees of muscle impairment and other complications. This case highlights the critical role of epigenetic in modulating disease expression, suggesting personalized therapeutic strategies are paramount even in siblings sharing the same homozygous variant.
A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps.
Pathogenic variants in the RYR1 gene have been associated with a variety of conditions, ranging from congenital myopathy to adult manifestations. Our aim was to characterize the p.Leu2286Val variant in 17 Basque patients, to accurately determine its correlation with clinical features and to explore the possible founder effect of the variant. Families harbouring the p.Leu2286 RYR1 variant underwent a detailed clinical evaluation, including muscle magnetic resonance imaging, electromyography and muscle biopsy. Haplotypes were analysed in available patients and their relatives. Individuals carrying the p.Leu2286Val shared a common haplotype, suggesting a founder event in the Basque Country population. The most prevalent features were exertional myalgia, high creatine kinase (CK) levels, cramps and muscle hypertrophy. None of the patients carrying only the p.Leu2286Val showed progression to severe muscle weakness and muscle magnetic resonance imaging showed a heterogeneous muscle involvement. Muscle biopsy revealed non-specific findings in two patients and features associated with central core disease in one patient carrying only the p.Leu2286Val and two patients harbouring an additional RYR1 variant. Three individuals carrying an in trans RYR1 variant presented with an earlier onset and more severe phenotype. Here, it is shown that the dominantly inherited p.Leu2286Val RYR1 founder variant is associated with a milder phenotype of exercise intolerance, myalgia and hyperCKemia.
RYR1-Related Myopathies Involve More than Calcium Dysregulation: Insights from Transcriptomic Profiling.
Ryanodine receptor 1-related myopathies (RYR1-RM) are caused by RYR1 gene variants and comprise a wide spectrum of histopathological manifestations. Here, we focus on patients carrying RYR1 variants and muscle histopathology consistent with central core disease (CCD) or multi-minicore disease (MmD). RNA-sequencing analyses of skeletal muscle biopsies obtained from both CCD and MmD patients and from healthy controls were performed to better understand the molecular pathways activated by RYR1 variants. Our analyses revealed that, beyond the well-established role of RYR1 in calcium homeostasis, broader cellular pathways are implicated. In CCD, differentially expressed genes were enriched for pathways related to oxidative stress response, SMAD signalling, and apoptosis, consistent with the role of intracellular calcium dysregulation in promoting mitochondrial dysfunction and cell death. In contrast, MmD patients exhibited enrichment of pathways related to immune activation. This was corroborated by the upregulation of GTPase-regulating genes and the down-regulation of transcriptional repressors such as ZFP36 and ATN1. When considering all RYR1-RM patients collectively, Wnt signalling, immune-related pathways, and oxidative phosphorylation emerged as shared enriched pathways, indicating possible convergent mechanisms across histopathological phenotypes. Our study suggests that complex gene regulation driven by RYR1 variants may be a unifying feature in CCD and MmD, offering new insight into potential therapeutic targets.
Publicações recentes
Molecular Insights into Central Core Disease: Proteomic Signatures and Potential Therapeutic Biomarkers in RYR1 I4895T Mice.
RYR1-Related Myopathies Involve More than Calcium Dysregulation: Insights from Transcriptomic Profiling.
Muscle imaging of patients with RYR1-related myopathies and its significance to clinical features.
Ca(2+), ROS, IL-6, and p38 MAPK signaling loops underlying alterations in myotube formation induced by a severe MH/CCD mutation in RyR1.
Therapeutic Challenges in Managing Triple-Negative Breast Cancer in a Patient With Central Core Disease.
📚 EuropePMC192 artigos no totalmostrando 100
Molecular Insights into Central Core Disease: Proteomic Signatures and Potential Therapeutic Biomarkers in RYR1 I4895T Mice.
International journal of molecular sciencesRYR1-Related Myopathies Involve More than Calcium Dysregulation: Insights from Transcriptomic Profiling.
BiomoleculesMuscle imaging of patients with RYR1-related myopathies and its significance to clinical features.
Neuromuscular disorders : NMDCa2+, ROS, IL-6, and p38 MAPK signaling loops underlying alterations in myotube formation induced by a severe MH/CCD mutation in RyR1.
American journal of physiology. Cell physiologyTherapeutic Challenges in Managing Triple-Negative Breast Cancer in a Patient With Central Core Disease.
CureusTwo journeys, one diagnosis: exploring the clinical outcomes of twins with congenital myopathy.
BMC neurologyLimited pre-clinical relevance of the heterozygous RYR1-I4895T/+ mouse model due to its mild phenotype.
Journal of neuromuscular diseasesA systematic review on motor outcome measures in congenital myopathy.
Neuromuscular disorders : NMDPerioperative management of cesarean section in pregnant women complicated by central core disease: A case report and literature review.
MedicineReport of joint hypermobility in malignant hyperthermia susceptible patients: Observational study with a case-control descriptive design.
HeliyonA founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps.
European journal of neurologyDantrolene inhibition of ryanodine receptor 1 carrying the severe malignant hyperthermia mutation Y522S visualized by cryo-EM.
Structure (London, England : 1993)Functional benefit of CRISPR-Cas9-induced allele deletion for RYR1 dominant mutation.
Molecular therapy. Nucleic acids[Clinical features and genetic analysis of a child with Central core disease due to compound heterozygous variants of RYR1 gene].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsPerioperative management of bronchoscopy in a child patient with central core disease: A case report and literature review.
International journal of surgery case reportsGeneration of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene.
Stem cell researchGeneration of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene.
Stem cell researchAnesthetic Management of a Patient With Central Core Disease Undergoing Thoracoscopic Lung Resection: The Importance of Neuromuscular Monitoring at the Masseter Muscle.
CureusRycal S48168 (ARM210) for RYR1-related myopathies: a phase one, open-label, dose-escalation trial.
EClinicalMedicineA case report of central core disease with repeated foaming at the mouth as the initial symptom.
MedicineGeneration of two induced pluripotent stem cell lines from a 33-year-old central core disease patient with a heterozygous dominant c.14145_14156delCTACTGGGACA (p.Asn4715_Asp4718del) deletion in the RYR1 gene.
Stem cell researchA brief history of the congenital myopathies - the myopathological perspective.
Neuromuscular disorders : NMDPancreatitis in RYR1-related disorders.
Neuromuscular disorders : NMDRhabdomyosarcoma Associated with Core Myopathy/Malignant Hyperthermia: Combined Effect of Germline Variants in RYR1 and ASPSCR1 May Play a Role.
GenesA novel RYR1 variant in an infant with a unique fetal presentation of central core disease.
American journal of medical genetics. Part ADrug development for the treatment of RyR1-related skeletal muscle diseases.
Current opinion in pharmacologyLoss-of-rescue of Ryr1I4895T-related pathology by the genetic inhibition of the ER stress response mediator CHOP.
Scientific reportsPharmacokinetics of Dantrolene in the Plasma Exchange Treatment of Malignant Hyperthermia in a 14-Year-Old Chinese Boy: A Case Report and Literature Review.
Frontiers in medicineMolecular mechanism of the severe MH/CCD mutation Y522S in skeletal ryanodine receptor (RyR1) by cryo-EM.
Proceedings of the National Academy of Sciences of the United States of America[Clinical characteristics and genetic analysis of a pedigree affected with neonatal central core disease].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsStructural Insight Into Ryanodine Receptor Channelopathies.
Frontiers in pharmacologyA review of major causative genes in congenital myopathies.
Journal of human geneticsCentral Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms.
GenesCongenital myopathies: The current status.
Indian journal of pathology & microbiologyExpanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study.
Acta neuropathologica communicationsVariant landscape of the RYR1 gene based on whole genome sequencing of the Singaporean population.
Scientific reportsMutation in RyR2-FKBP Binding site alters Ca2+ signaling modestly but increases "arrhythmogenesis" in human stem cells derived cardiomyocytes.
Cell calciumA review of core myopathy: central core disease, multiminicore disease, dusty core disease, and core-rod myopathy.
Neuromuscular disorders : NMDA recurrent RYR1 mutation associated with early-onset hypotonia and benign disease course.
Acta neuropathologica communicationsThe mitochondrial calcium homeostasis orchestra plays its symphony: Skeletal muscle is the guest of honor.
International review of cell and molecular biologyMarked Facial Weakness, Ptosis, and Hanging Jaw: A Case with RYR1 -Related Congenital Centronuclear Myopathy.
Journal of pediatric geneticsAsymmetrical anterior thigh muscle atrophy as an atypical presentation of RYR1-core myopathy.
Neuromuscular disorders : NMDAltered Ca2+ Handling and Oxidative Stress Underlie Mitochondrial Damage and Skeletal Muscle Dysfunction in Aging and Disease.
MetabolitesA case of dermatomyositis in a patient with central core disease: unusual association with autoimmunity and genetic muscle disease.
Pediatric rheumatology online journalCongenital Myopathies: A Clinicopathological Study of 10 Cases in a Tertiary Care Hospital of North India.
Journal of pediatric neurosciencesDominant or recessive mutations in the RYR1 gene causing central core myopathy in Brazilian patients.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of MyologyCore myopathies - a short review.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of MyologyNovel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark cores.
Neuromuscular disorders : NMDEvaluation of the Core Formation Process in Congenital Neuromuscular Disease With Uniform Type 1 Fiber and Central Core Disease.
Journal of neuropathology and experimental neurologyIn vivo RyR1 reduction in muscle triggers a core-like myopathy.
Acta neuropathologica communicationsNew Compound Heterozygous Splice Site Mutations of the Skeletal Muscle Ryanodine Receptor (RYR1) Gene Manifest Fetal Akinesia: A Linkage with Congenital Myopathies.
Molecular syndromologyManagement of pregnancy complicated by central core disease.
International journal of obstetric anesthesiaThirty years of translational research in Mobility Medicine: Collection of abstracts of the 2020 Padua Muscle Days.
European journal of translational myologyBi-allelic expression of the RyR1 p.A4329D mutation decreases muscle strength in slow-twitch muscles in mice.
The Journal of biological chemistryPreclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.
Orphanet journal of rare diseasesClinical Observation: Effect of a Second Transpositioned Variant in a Family with Autosomal Dominant Ryanodine Receptor-1-Related Disease.
Journal of pediatric geneticsIntracellular calcium leak as a therapeutic target for RYR1-related myopathies.
Acta neuropathologicaSingle Amino Acid Changes in the Ryanodine Receptor in the Human Population Have Effects In Vivo on Caenorhabditis elegans Neuro-Muscular Function.
Frontiers in geneticsImpact of scoliosis surgery on pulmonary function in patients with muscular dystrophies and spinal muscular atrophy.
Pediatric pulmonologyCored in the act: the use of models to understand core myopathies.
Disease models & mechanismsSignificance of Asymptomatic Hyper Creatine-Kinase Emia.
Journal of clinical neuromuscular diseaseFunctional Electrical Stimulation: A Possible Strategy to Improve Muscle Function in Central Core Disease?
Frontiers in neurologyA central core disease mutation in the Ca2+-binding site of skeletal muscle ryanodine receptor impairs single-channel regulation.
American journal of physiology. Cell physiologyRYR1 Sequence Variants in Myopathies: Expression and Functional Studies in Two Families.
BioMed research internationalTherapeutic Aspects in Congenital Myopathies.
Seminars in pediatric neurologyPregnancy and Delivery in Women With Congenital Myopathies.
Seminars in pediatric neurologySevere Neonatal RYR1 Myopathy With Pathological Features of Congenital Muscular Dystrophy.
Journal of neuropathology and experimental neurologyHomozygous/compound heterozygote RYR1 gene variants: Expanding the clinical spectrum.
American journal of medical genetics. Part A'Dusty core disease' (DuCD): expanding morphological spectrum of RYR1 recessive myopathies.
Acta neuropathologica communicationsRyanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeuticsDisturbed Ca2+ Homeostasis in Muscle-Wasting Disorders.
Advances in experimental medicine and biologyCalcium Channelopathies: Structural Insights into Disorders of the Muscle Excitation-Contraction Complex.
Annual review of geneticsCharacterization of congenital myopathies at a Korean neuromuscular center.
Muscle & nerveClinical and Pathologic Findings of Korean Patients with RYR1-Related Congenital Myopathy.
Journal of clinical neurology (Seoul, Korea)Parental mosaicism in RYR1-related Central Core Disease.
Neuromuscular disorders : NMDCentral core disease with scoliosis for congenital hip dislocation surgery: An anaesthetic demur.
Indian journal of anaesthesiaCongenital myopathies: disorders of excitation-contraction coupling and muscle contraction.
Nature reviews. NeurologyAntioxidant Treatment Reduces Formation of Structural Cores and Improves Muscle Function in RYR1Y522S/WT Mice.
Oxidative medicine and cellular longevityCommon and variable clinical, histological, and imaging findings of recessive RYR1-related centronuclear myopathy patients.
Neuromuscular disorders : NMDReduced threshold for store overload-induced Ca2+ release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease.
The Biochemical journalIon-pulling simulations provide insights into the mechanisms of channel opening of the skeletal muscle ryanodine receptor.
The Journal of biological chemistryWhole exome sequencing of a patient with suspected mitochondrial myopathy reveals novel compound heterozygous variants in RYR1.
Molecular genetics & genomic medicineFunctional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia.
Journal of neuromuscular diseasesYoung onset Parkinsonism in a patient with familial central core disease.
Neurology IndiaFunctional Characterization of a Central Core Disease RyR1 Mutation (p.Y4864H) Associated with Quantitative Defect in RyR1 Protein.
Journal of neuromuscular diseasesMalignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
American journal of physiology. Cell physiologyGenotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
Human mutationCongenital myopathies: not only a paediatric topic.
Current opinion in neurologyCurrent and future therapeutic approaches to the congenital myopathies.
Seminars in cell & developmental biology[Anesthetic Management of a Patient with Central Core Disease for Scoliosis Surgery].
Masui. The Japanese journal of anesthesiologyCoexistence of central nucleus, cores, and rods: Diagnostic relevance.
Annals of Indian Academy of NeurologyNext generation sequencing reveals ryanodine receptor 1 mutations in a Chinese central core disease cohort.
Muscle & nerveBilateral congenital lumbar hernias in a patient with central core disease--A case report.
Neuromuscular disorders : NMDNovel pathogenic variants and genes for myopathies identified by whole exome sequencing.
Molecular genetics & genomic medicineDivergent Activity Profiles of Type 1 Ryanodine Receptor Channels Carrying Malignant Hyperthermia and Central Core Disease Mutations in the Amino-Terminal Region.
PloS oneOxidative stress, mitochondrial damage, and cores in muscle from calsequestrin-1 knockout mice.
Skeletal muscleA novel large deletion in the RYR1 gene in a Belgian family with late-onset and recessive core myopathy.
Neuromuscular disorders : NMDTwo families with MYH7 distal myopathy associated with cardiomyopathy and core formations.
Journal of clinical neuromuscular diseaseMild Clinical Features and Histopathologically Atypical Cores in Two Korean Families with Central Core Disease Harboring RYR1 Mutations at the C-Terminal Region.
Journal of clinical neurology (Seoul, Korea)Potassium dependent rescue of a myopathy with core-like structures in mouse.
eLifeAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Doença do núcleo central.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Doença do núcleo central
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Molecular Insights into Central Core Disease: Proteomic Signatures and Potential Therapeutic Biomarkers in RYR1 I4895T Mice.
- Ca2+, ROS, IL-6, and p38 MAPK signaling loops underlying alterations in myotube formation induced by a severe MH/CCD mutation in RyR1.
- Two journeys, one diagnosis: exploring the clinical outcomes of twins with congenital myopathy.
- A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps.
- RYR1-Related Myopathies Involve More than Calcium Dysregulation: Insights from Transcriptomic Profiling.
- Muscle imaging of patients with RYR1-related myopathies and its significance to clinical features.
- Therapeutic Challenges in Managing Triple-Negative Breast Cancer in a Patient With Central Core Disease.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:597(Orphanet)
- OMIM OMIM:117000(OMIM)
- MONDO:0007294(MONDO)
- GARD:6014(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q638975(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
